Spindler, K. G., Pallisgaard, N., Lindebjerg, J., Frifeldt, S. K., & Jakobsen, A. (2011). EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer. BioMed Central.
Citação norma ChicagoSpindler, Karen-Lise G., Niels Pallisgaard, Jan Lindebjerg, Sanne K. Frifeldt, and Anders Jakobsen. EGFR Related Mutational Status and Association to Clinical Outcome of Third-line Cetuximab-irinotecan in Metastatic Colorectal Cancer. BioMed Central, 2011.
Citação norma MLASpindler, Karen-Lise G., et al. EGFR Related Mutational Status and Association to Clinical Outcome of Third-line Cetuximab-irinotecan in Metastatic Colorectal Cancer. BioMed Central, 2011.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.